Teledyne Technologies Operating Cash Flow decreased by 38.3% to $234.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.5%, from $242.60M to $234.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 9.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $211.30M | $192.80M | $295.60M | -$216.70M | $196.90M | $268.90M | $237.70M | $203.00M | $190.50M | $278.20M | $164.40M | $291.00M | $318.70M | $249.80M | $332.40M | $242.60M | $226.60M | $343.10M | $379.00M | $234.00M |
| QoQ Change | — | -8.8% | +53.3% | -173.3% | +190.9% | +36.6% | -11.6% | -14.6% | -6.2% | +46.0% | -40.9% | +77.0% | +9.5% | -21.6% | +33.1% | -27.0% | -6.6% | +51.4% | +10.5% | -38.3% |
| YoY Change | — | — | — | — | -6.8% | +39.5% | -19.6% | +193.7% | -3.3% | +3.5% | -30.8% | +43.3% | +67.3% | -10.2% | +102.2% | -16.6% | -28.9% | +37.3% | +14.0% | -3.5% |